Upcoming Dividend • Apr 30
Upcoming dividend of S$0.027 per share Eligible shareholders must have bought the stock before 07 May 2026. Payment date: 28 May 2026. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 4.6%. Lower than top quartile of Singaporean dividend payers (5.0%). Lower than average of industry peers (5.7%). Reported Earnings • Apr 18
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CN¥0.42 (down from CN¥0.44 in FY 2024). Revenue: CN¥3.28b (down 6.8% from FY 2024). Net income: CN¥404.9m (down 4.5% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 6.9%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Announcement • Apr 15
China Sunsine Chemical Holdings Ltd., Annual General Meeting, Apr 29, 2026 China Sunsine Chemical Holdings Ltd., Annual General Meeting, Apr 29, 2026, at 10:00 Singapore Standard Time. Location: skai suite 3 & 4 @ level 69, swissotel the stamford, 2 stamford road singapore 178882, Singapore Declared Dividend • Apr 10
Final dividend of S$0.027 announced Shareholders will receive a dividend of S$0.027. Ex-date: 7th May 2026 Payment date: 28th May 2026 Dividend yield will be 4.8%, which is lower than the industry average of 7.1%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (43% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 8.7% over the next 3 years, which should provide support to the dividend and adequate earnings cover. New Risk • Mar 07
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 2.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.0% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Price Target Changed • Mar 04
Price target decreased by 26% to S$0.70 Down from S$0.95, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of S$0.69. Stock is up 44% over the past year. The company is forecast to post earnings per share of CN¥0.42 for next year compared to CN¥0.42 last year. Reported Earnings • Mar 03
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CN¥0.42 (down from CN¥0.44 in FY 2024). Revenue: CN¥3.28b (down 6.8% from FY 2024). Net income: CN¥404.9m (down 4.5% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 6.9%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Announcement • Feb 14
China Sunsine Chemical Holdings Ltd. to Report Second Half, 2025 Results on Feb 27, 2026 China Sunsine Chemical Holdings Ltd. announced that they will report second half, 2025 results on Feb 27, 2026 Price Target Changed • Nov 13
Price target increased by 29% to S$0.75 Up from S$0.58, the current price target is provided by 1 analyst. New target price is 8.5% below last closing price of S$0.82. Stock is up 91% over the past year. The company is forecast to post earnings per share of CN¥0.46 for next year compared to CN¥0.44 last year. Price Target Changed • Sep 18
Price target increased by 11% to S$0.61 Up from S$0.55, the current price target is an average from 2 analysts. New target price is 25% below last closing price of S$0.81. Stock is up 101% over the past year. The company is forecast to post earnings per share of CN¥0.46 for next year compared to CN¥0.44 last year. Price Target Changed • Aug 18
Price target increased by 10% to S$0.58 Up from S$0.53, the current price target is an average from 2 analysts. New target price is 17% below last closing price of S$0.69. Stock is up 81% over the past year. The company is forecast to post earnings per share of CN¥0.46 for next year compared to CN¥0.44 last year. Reported Earnings • Aug 17
First half 2025 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 1H 2024) First half 2025 results: EPS: CN¥0.26 (up from CN¥0.20 in 1H 2024). Revenue: CN¥1.69b (down 3.4% from 1H 2024). Net income: CN¥242.7m (up 28% from 1H 2024). Profit margin: 14% (up from 11% in 1H 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. New Risk • Aug 14
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 1.0% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Announcement • Jul 30
China Sunsine Chemical Holdings Ltd. to Report First Half, 2025 Results on Aug 13, 2025 China Sunsine Chemical Holdings Ltd. announced that they will report first half, 2025 results on Aug 13, 2025 Upcoming Dividend • Apr 30
Upcoming dividend of S$0.03 per share Eligible shareholders must have bought the stock before 07 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 5.5%. Lower than top quartile of Singaporean dividend payers (6.0%). Lower than average of industry peers (8.0%). Reported Earnings • Apr 16
Full year 2024 earnings: EPS exceeds analyst expectations Full year 2024 results: EPS: CN¥0.44 (up from CN¥0.39 in FY 2023). Revenue: CN¥3.52b (flat on FY 2023). Net income: CN¥423.9m (up 14% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 13%. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Major Estimate Revision • Mar 30
Consensus EPS estimates increase by 10%, revenue downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from CN¥3.72b to CN¥3.66b. EPS estimate rose from CN¥0.419 to CN¥0.461. Net income forecast to grow 3.5% next year vs 30% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.53 to S$0.55. Share price rose 3.8% to S$0.55 over the past week. Declared Dividend • Mar 28
Dividend of S$0.03 announced Shareholders will receive a dividend of S$0.03. Ex-date: 7th May 2025 Payment date: 22nd May 2025 Dividend yield will be 5.5%, which is lower than the industry average of 7.1%. Sustainability & Growth Dividend is well covered by both earnings (24% earnings payout ratio) and cash flows (34% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 8.3% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • Mar 26
China Sunsine Chemical Holdings Ltd., Annual General Meeting, Apr 29, 2025 China Sunsine Chemical Holdings Ltd., Annual General Meeting, Apr 29, 2025. Price Target Changed • Mar 26
Price target increased by 11% to S$0.55 Up from S$0.50, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of S$0.55. Stock is up 35% over the past year. The company is forecast to post earnings per share of CN¥0.46 for next year compared to CN¥0.44 last year. Reported Earnings • Mar 01
Full year 2024 earnings: EPS exceeds analyst expectations Full year 2024 results: EPS: CN¥0.44 (up from CN¥0.39 in FY 2023). Revenue: CN¥3.52b (flat on FY 2023). Net income: CN¥423.9m (up 14% from FY 2023). Profit margin: 12% (up from 11% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 13%. Revenue is forecast to grow 4.1% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • Feb 17
China Sunsine Chemical Holdings Ltd. to Report Q4, 2024 Results on Feb 28, 2025 China Sunsine Chemical Holdings Ltd. announced that they will report Q4, 2024 results After-Market on Feb 28, 2025 Reported Earnings • Aug 16
First half 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.20 in 1H 2023) First half 2024 results: EPS: CN¥0.20 (down from CN¥0.20 in 1H 2023). Revenue: CN¥1.75b (up 1.2% from 1H 2023). Net income: CN¥188.8m (down 3.0% from 1H 2023). Profit margin: 11% (in line with 1H 2023). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 10% per year and the company’s share price has also fallen by 10% per year. Announcement • Aug 01
China Sunsine Chemical Holdings Ltd. to Report Q2, 2024 Results on Aug 13, 2024 China Sunsine Chemical Holdings Ltd. announced that they will report Q2, 2024 results After-Market on Aug 13, 2024 Board Change • May 02
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Cheng Liang was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 14
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: CN¥0.39 (down from CN¥0.66 in FY 2022). Revenue: CN¥3.49b (down 8.7% from FY 2022). Net income: CN¥372.5m (down 42% from FY 2022). Profit margin: 11% (down from 17% in FY 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Declared Dividend • Mar 07
Dividend of S$0.025 announced Shareholders will receive a dividend of S$0.025. Ex-date: 9th May 2024 Payment date: 24th May 2024 Dividend yield will be 6.4%, which is lower than the industry average of 7.1%. Sustainability & Growth Dividend is well covered by both earnings (21% earnings payout ratio) and cash flows (31% cash payout ratio). The dividend has increased by an average of 19% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 12% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • Mar 06
China Sunsine Chemical Holdings Ltd., Annual General Meeting, Apr 26, 2024 China Sunsine Chemical Holdings Ltd., Annual General Meeting, Apr 26, 2024. Agenda: To approve Final Dividend. Reported Earnings • Mar 02
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: CN¥0.39 (down from CN¥0.66 in FY 2022). Revenue: CN¥3.49b (down 8.7% from FY 2022). Net income: CN¥372.4m (down 42% from FY 2022). Profit margin: 11% (down from 17% in FY 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Revenue is forecast to grow 4.9% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Announcement • Feb 21
China Sunsine Chemical Holdings Ltd. to Report Second Half, 2023 Results on Feb 29, 2024 China Sunsine Chemical Holdings Ltd. announced that they will report second half, 2023 results on Feb 29, 2024 Major Estimate Revision • Nov 17
Consensus EPS estimates fall by 18% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from CN¥0.416 to CN¥0.34 per share. Revenue forecast steady at CN¥3.59b. Net income forecast to shrink 13% next year vs 39% growth forecast for Chemicals industry in Singapore . Consensus price target of S$0.47 unchanged from last update. Share price was steady at S$0.39 over the past week. Announcement • Aug 17
China Sunsine Chemical Holdings Ltd. Appoints Yuan Jiale as Deputy General Manager (Sales and Marketing), Effective from August 15, 2023 China Sunsine Chemical Holdings Ltd. announced appointment of Yuan Jiale as Deputy General Manager (Sales and Marketing), effective from August 15, 2023. Working Experience: April 2022 - August 2023 General Manager Assistant in charge of Marketing Department, Shandong Sunsine Chemical Co., Ltd; April 2021 - March 2022 Director of Marketing Department, Shandong Sunsine Chemical Co., Ltd; December 2019 - March 2021 Vice Director of Marketing Department, Shandong Sunsine Chemical Co., Ltd; July 2008 - November 2019 Staff of International Sales Department, Shandong Sunsine Chemical Co. Ltd. Reported Earnings • Aug 16
First half 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.44 in 1H 2022) First half 2023 results: EPS: CN¥0.20 (down from CN¥0.44 in 1H 2022). Revenue: CN¥1.73b (down 14% from 1H 2022). Net income: CN¥194.6m (down 55% from 1H 2022). Profit margin: 11% (down from 21% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. New Risk • Aug 15
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 12% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (12% net profit margin). Announcement • Aug 03
China Sunsine Chemical Holdings Ltd. to Report First Half, 2023 Results on Aug 14, 2023 China Sunsine Chemical Holdings Ltd. announced that they will report first half, 2023 results on Aug 14, 2023 Upcoming Dividend • May 02
Upcoming dividend of S$0.025 per share at 5.4% yield Eligible shareholders must have bought the stock before 09 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 7.8% and the cash payout ratio is 97%. Trailing yield: 5.4%. Lower than top quartile of Singaporean dividend payers (6.4%). Higher than average of industry peers (3.6%). Major Estimate Revision • Apr 29
Consensus EPS estimates fall by 18% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥3.77b to CN¥3.65b. EPS estimate also fell from CN¥0.516 per share to CN¥0.426 per share. Net income forecast to shrink 36% next year vs 25% growth forecast for Chemicals industry in Singapore . Consensus price target down from S$0.59 to S$0.53. Share price fell 3.2% to S$0.46 over the past week. Reported Earnings • Apr 14
Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2022 results: EPS: CN¥0.66 (up from CN¥0.52 in FY 2021). Revenue: CN¥3.83b (up 2.7% from FY 2021). Net income: CN¥642.4m (up 27% from FY 2021). Profit margin: 17% (up from 14% in FY 2021). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) exceeded analyst estimates by 2.9%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 01
Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2022 results: EPS: CN¥0.66 (up from CN¥0.52 in FY 2021). Revenue: CN¥3.83b (up 2.7% from FY 2021). Net income: CN¥642.4m (up 27% from FY 2021). Profit margin: 17% (up from 14% in FY 2021). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) exceeded analyst estimates by 2.9%. Revenue is forecast to stay flat during the next 2 years compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Announcement • Feb 17
China Sunsine Chemical Holdings Ltd. to Report Fiscal Year 2022 Results on Feb 28, 2023 China Sunsine Chemical Holdings Ltd. announced that they will report fiscal year 2022 results at 5:00 PM, Singapore Standard Time on Feb 28, 2023 Price Target Changed • Nov 16
Price target decreased to S$0.60 Down from S$0.70, the current price target is provided by 1 analyst. New target price is 38% above last closing price of S$0.43. Stock is down 16% over the past year. The company is forecast to post earnings per share of CN¥0.63 for next year compared to CN¥0.52 last year. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. GM of Shandong Sunsine & Executive Director De Ming Liu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. GM of Shandong Sunsine & Executive Director De Ming Liu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. GM of Shandong Sunsine & Executive Director De Ming Liu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Aug 18
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from CN¥4.15b to CN¥4.03b. EPS estimate rose from CN¥0.53 to CN¥0.61. Net income forecast to shrink 13% next year vs 22% growth forecast for Chemicals industry in Singapore . Consensus price target up from S$0.68 to S$0.70. Share price rose 3.1% to S$0.49 over the past week. Reported Earnings • Aug 13
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down CN¥265.2m from profit in 1H 2021). Profit margin: (down from 15% in 1H 2021). The decrease in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 7.2%, compared to a 24% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Aug 12
China Sunsine Chemical Holdings Ltd. Proposes Special Interim Dividend for the Financial Year Ending 31 December 2022, Payable on 9 September 2022 China Sunsine Chemical Holdings Ltd. announced that the Share Transfer Books and Register of Members of the Company will be closed at 5.00 p.m. on 22 August 2022 (the Record Date), for the purpose of determining shareholders' entitlements to a special interim dividend (one-tier tax exempt) of 0.5 Singapore cent per ordinary share for the financial year ending 31 December 2022 (the Proposed Special Dividend). Payment of the Proposed Special Dividend will be made on 9 September 2022. Upcoming Dividend • May 02
Upcoming dividend of S$0.02 per share Eligible shareholders must have bought the stock before 09 May 2022. Payment date: 24 May 2022. Payout ratio is a comfortable 9.0% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of Singaporean dividend payers (5.8%). Higher than average of industry peers (1.4%). Price Target Changed • Apr 27
Price target increased to S$0.74 Up from S$0.69, the current price target is an average from 2 analysts. New target price is 59% above last closing price of S$0.47. Stock is down 19% over the past year. The company is forecast to post earnings per share of CN¥0.51 for next year compared to CN¥0.52 last year. Reported Earnings • Apr 15
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥0.52 (up from CN¥0.23 in FY 2020). Revenue: CN¥3.73b (up 60% from FY 2020). Net income: CN¥506.3m (up 131% from FY 2020). Profit margin: 14% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.5%. Earnings per share (EPS) also surpassed analyst estimates by 9.6%. Over the next year, revenue is forecast to grow 6.5%, compared to a 29% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Announcement • Apr 13
China Sunsine Chemical Holdings Ltd. Proposes Final One-Tier Tax Exempt Dividend for the Financial Year Ended 31 December 2021, Payable on 24 May 2022 China Sunsine Chemical Holdings Ltd. proposed to approve the final one-tier tax exempt dividend of 1 Singapore cent per ordinary share for the financial year ended 31 December 2021 in Annual General Meeting to be held on 29 April 2022. The Proposed Final Dividend, if approved by shareholders at the Annual General Meeting, will be paid on 24 May 2022 with record date of 10 May 2022. Major Estimate Revision • Mar 02
Consensus EPS estimates increase by 18% The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from CN¥3.74b to CN¥3.97b. EPS estimate increased from CN¥0.43 to CN¥0.51 per share. Net income forecast to shrink 3.2% next year vs 23% growth forecast for Chemicals industry in Singapore . Consensus price target of S$0.74 unchanged from last update. Share price fell 6.9% to S$0.47 over the past week. Reported Earnings • Feb 24
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥0.52 (up from CN¥0.23 in FY 2020). Revenue: CN¥3.73b (up 60% from FY 2020). Net income: CN¥506.3m (up 131% from FY 2020). Profit margin: 14% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.5%. Earnings per share (EPS) also surpassed analyst estimates by 9.6%. Over the next year, revenue is forecast to stay flat compared to a 28% growth forecast for the industry in Singapore. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Announcement • Feb 13
China Sunsine Chemical Holdings Ltd. Provides Consolidated Earnings Guidance for the Second Half and Full Year Ended 31 December 2021 China Sunsine Chemical Holdings Ltd. provided consolidated earnings guidance for the second half and full year ended 31 December 2021. The Board of Directors of the company informed shareholders and potential investors of the company that, based on the preliminary assessment of the information currently available to the Board, including the unaudited interim financial statements for the second half and full year ended 31 December 2021, the group is expected to report a material increase in its consolidated net profit, compared to the corresponding period in 2020. Price Target Changed • Dec 21
Price target increased to S$0.74 Up from S$0.69, the current price target is an average from 3 analysts. New target price is 54% above last closing price of S$0.48. Stock is down 5.0% over the past year. The company is forecast to post earnings per share of CN¥0.48 for next year compared to CN¥0.22 last year. Executive Departure • Sep 07
Joint Company Secretary Lingna Dai has left the company On the 1st of September, Lingna Dai's tenure as Joint Company Secretary ended after 3.9 years in the role. We don't have any record of a personal shareholding under Lingna's name. A total of 3 executives have left over the last 12 months. Price Target Changed • May 23
Price target increased to S$0.68 Up from S$0.59, the current price target is an average from 3 analysts. New target price is 32% above last closing price of S$0.52. Stock is up 41% over the past year. Upcoming Dividend • May 02
Upcoming dividend of S$0.01 per share Eligible shareholders must have bought the stock before 07 May 2021. Payment date: 24 May 2021. Trailing yield: 1.8%. Lower than top quartile of Singaporean dividend payers (4.6%). In line with average of industry peers (1.8%). Major Estimate Revision • May 02
Consensus EPS estimates increase to CN¥0.34 The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥3.25b to CN¥3.38b. EPS estimate increased from CN¥0.31 to CN¥0.34 per share. Net income forecast to grow 51% next year vs 35% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.59 to S$0.61. Share price was steady at S$0.56 over the past week. Executive Departure • May 01
CEO & Executive Director Jing Fu Liu has left the company On the 30th of April, Jing Fu Liu's tenure as CEO & Executive Director of the company ended after 7.4 years in the role. As of December 2020, Jing Fu personally held 1.44m shares (S$713k worth at the time). A total of 3 executives have left over the last 12 months. Under Jing Fu's leadership, the company delivered a total shareholder return of 580%. Price Target Changed • Apr 12
Price target increased to S$0.59 Up from S$0.53, the current price target is an average from 3 analysts. New target price is 6.6% above last closing price of S$0.56. Stock is up 61% over the past year. Reported Earnings • Apr 09
Full year 2020 earnings released: EPS CN¥0.23 (vs CN¥0.40 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.33b (down 13% from FY 2019). Net income: CN¥218.8m (down 44% from FY 2019). Profit margin: 9.4% (down from 14% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Mar 09
New 90-day high: S$0.52 The company is up 2.0% from its price of S$0.51 on 09 December 2020. The Singaporean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is S$0.95 per share. Analyst Estimate Surprise Post Earnings • Feb 27
Earnings beat expectations, revenue disappoints Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 8.3%. Over the next year, revenue is forecast to grow 39%, compared to a 29% growth forecast for the Chemicals industry in Singapore. Reported Earnings • Feb 26
Full year 2020 earnings released The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.33b (down 13% from FY 2019). Net income: CN¥218.8m (down 44% from FY 2019). Profit margin: 9.4% (down from 14% in FY 2019). The decrease in margin was driven by lower revenue. Announcement • Feb 20
China Sunsine Chemical Holdings Ltd. to Report Fiscal Year 2020 Results on Feb 25, 2021 China Sunsine Chemical Holdings Ltd. announced that they will report fiscal year 2020 results After-Market on Feb 25, 2021 
